The hidden heart failure patient: optimising guideline-directed therapy
15 Oct 2024
Cardiovascular Professional Care Theatre
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Where else might a person with heart failure present in the hospital? How can the multi-disciplinary team support optimisation on guideline-directed medical therapy at the earliest opportunity?
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
)
){kind=logo}
){kind=logo}
